...
首页> 外文期刊>癌と化学療法 >A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP
【24h】

A case of liver metastasis of gastric cancer undergoing non-curative operation responding completely to combination therapy of S-1 and CDDP

机译:胃癌肝脏转移的情况,经历非疗效术后致响应S-1和CDDP的组合治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We experienced a case with liver metastasis of gastric cancer that disappeared by S-1 administration following non-curative operation. A distal gastrectomy for advanced gastric cancer with liver metastasis was performed on a 71-year-old male. S-1 was administered at 100 mg/body/day for 4 weeks followed by withdrawal for 2 weeks, and CDDP was prescribed at 5 mg/body/day div, for 2 days per a week as 1 course. After one course of treatment, the liver metastatic lesion decreased in size (reduction ratio was 87.4%). For side effect, S-1 100 mg alone was administered beginning with the second course. This lesion became CR after four courses. The adverse events of grade 3 observed during S-1 administration were neutropenia and diarrhea. We changed S-1 to UFT after nine courses, and the patient has now survived 1 year without recurrence after the disappearance of liver metastasis.
机译:我们经历了胃癌肝转移的情况,在非疗法操作后通过S-1给药消失。 在71岁的男性上进行了具有肝转移的晚期胃癌的远端胃切除术。 S-1在100毫克/体/日施用4周,然后撤离2周,CDDP在5毫克/体/天DIV处,每周2天为1课程。 在一次治疗后,肝转移性病变的尺寸减少(减少率为87.4%)。 对于副作用,从第二课程开始施用S-1 100mg。 这条课程后,这种病变成为CR。 在S-1施用期间观察到3级的不良事件是中性粒细胞蛋白和腹泻。 我们在九门课程后改变了S-1到UFT,现在肝脏转移消失后,患者现在已经存活了1年没有复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号